Dexmedetomidine for agitation in palliative care delirium
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether dexmedetomidine can help calm agitation caused by delirium in adults receiving palliative (comfort-focused) care. It may help reduce restlessness and distress when standard approaches may not be enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are an inpatient on a participating palliative care unit
- You currently have agitated delirium, or you had delirium in the last 6 months, or you are in the last two weeks of life and expected to die during this stay
- Your blood pressure is stable (systolic blood pressure must be 80 mmHg or higher)
- Your heart rate is not too slow at the start (baseline heart rate must be 60 beats per minute or higher)
- You are not taking verapamil, diltiazem, or beta-blockers—unless they can be stopped before dexmedetomidine is given
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a sedative drug (dexmedetomidine) to see if it helps calm agitation in patients with moderate or severe traumatic brain injury who are on a breathing machine in the ICU. The goal is to improve comfort and recovery.
This trial tests if combining two medicines, esketamine and dexmedetomidine, is better than dexmedetomidine alone for calming severe confusion and agitation in ICU patients who need breathing support through a mask or nasal tubes. It aims to find a safer, more effective way to help patients rest and recover.
This study tests whether a sedative medication called dexmedetomidine can reduce confusion and delirium in children who need mechanical ventilation (breathing machines) in the intensive care unit. Researchers want to see if it works better and safer than standard sedatives.
This trial tests whether a sedating medicine called dexmedetomidine can reduce the risk of “delirium” (sudden confusion) in the intensive care unit after open-heart surgery. If you’re having certain heart operations, it may help protect your thinking and alertness during recovery.
This trial tests whether a sedative called dexmedetomidine can reduce agitation in ICU patients when they are being weaned off a breathing tube. If you experience restlessness or agitation during the weaning process, this medication might help you stay calm.
This trial tests two different medications to quickly calm severe agitation in people admitted to a psychiatric emergency room. You may be able to join if you are extremely agitated and need urgent medication to help you settle down.
Hear when a new Hyperactive Delirium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.